Latest filing published 14 Oct 2026 for Medpace Holdings, Inc., €446k. Read the official filing
This profile gathers the share dealings of Susan e. Burwig in Medpace Holdings, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 14 June 2021 to 12 October 2026, the count stands at 24 filings.
Sales make up the whole of the open-market record (10 sales, €46.7M). Outside the open market, there are 14 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
The newest entry dates from 14 October 2026: an option exercise of €446k, in Medpace Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations